期刊文献+

2014年早孕期母血清产前筛查检验项目室内质控结果调查与分析 被引量:3

Investigation and analysis on internal quality control results of maternal serum prenatal screening project during the first trimester of pregnancy in 2014
原文传递
导出
摘要 目的:分析2014年全国早孕期母血清产前筛查检验项目室内质量控制情况。方法:收集2014年参加卫生部临床检验中心室间质评参评单位回报的室内质控信息,将变异系数与1/3TEa(10%)、1/4TEa(7.5%)以及5%进行比较,得到满足各标准实验室的比例,从而分析全国早孕目血清产前筛查检验项目的室内质控情况。结果:80%以上的实验室不精密度都能达到1/3TEa的标准,达到1/4TEa标准的实验室比例略有降低,而不精密度达到5%的仅50%左右。结论:各项目的室内质控精密度水平离国内行业标准还有很大差距,各实验室应建立严格的室内质控制度,提高产前筛查项目的精密度水平。 Objective: To analyze internal quality control( IQC) results of maternal serum prenatal screening project during the first trimester of pregnancy in 2014. Methods: IQC information was collected in 2014,then the coefficient of variation was compared with1 /3TEa( 10%),1 /4TEa( 7. 5%) and 5%. The proportions of laboratories meeting the standards were obtained,IQC situation of maternal serum prenatal screening project during the first trimester of pregnancy in China was analyzed. Results: The imprecision of more than 80%of the participant laboratories achieved 1 /3Tea standard,the proportion of participant laboratories with imprecision achieving 1 /4TEa standard decreased slightly,the imprecision of only 50% of the participant laboratories achieved 5%. Conclusion: There is a big gap in IQC precision between maternal serum prenatal screening project and national industry standard. Laboratories should establish strict IQC system and improve IQC precision of maternal serum prenatal screening project.
出处 《中国妇幼保健》 CAS 2015年第8期1235-1236,共2页 Maternal and Child Health Care of China
基金 北京市自然科学基金项目〔7143182〕
关键词 早孕期产前筛查 室内质量控制 变异系数 Prenatal screening during the first trimester of pregnancy Internal quality control Coefficient of variation
  • 相关文献

参考文献5

二级参考文献35

  • 1朱宝生,边旭明.“中孕期母血清学产前筛查技术标准”解读[J].中国产前诊断杂志(电子版),2012,4(4):1-5. 被引量:9
  • 2中华人民共和国卫生行业标准.胎儿常见染色体异常与开放性神经管缺陷的产前筛查与诊断技术标准第1部分:中孕期母血清学产前筛查.2010.
  • 3中华人民共和国卫生部《产前诊断技术管理办法》附件5.21三体综合征和神经管缺陷产前筛查技术规范.2002.
  • 4Palomaki GE, Bradley LA, McDowell GA. Technical standards and guidelines, prenatal screening for Down syndrome. Genet Med, 2005,7: 344-354.
  • 5NHS. Fetal Anomaly Screening Programmes. Annual Report: 2008-2009.
  • 6National protocols : NHSScotland Screening Programmes-Pregnancyand Newborn Screening: Fetal Anomaly and Down's syndrome screening, 19-27, version 2, 2011.
  • 7Wald NJ, Kennard A, Hackshaw A, et al. Antenatal screeningfor Down's syndrome. J Med Screen, 1997, 4: 181-246.
  • 8Knight GJ, Palomaki GE. Epidemiologic monitoring of prenatalscreening for neural tube defects and Down syndrome. Clin Lab Med, 2003,22:531-551.
  • 9王治国.临床检验方法确认与性能验证[M].北京:人民卫生出版社,2012.
  • 10Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum[ J]. Lancet, 1997,350:485-487.

共引文献44

同被引文献17

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部